Atif J. Khan, M.D., M.S.

Asistant Professor

Tel:   732-253-3939
Emai:   Khanat@umdnj.edu

Education:

• M.D.              Aga Khan University Medical College
• Residency     Rush University Medical Center, Rush University
• Fellowship    Brigham and Women's Hospital, Harvard Medical School

Academic Appointments:

• Assistant Professor

Honors/Certificates:

• NCCN Fellow 2003
• NCCN fellow 2005
• ACRO resident travel grant 2005
• Lynn Sage Fellow grant 2005
• Certificate of American Board of Radiology (Board Certified)

Clinical Interests:

• Brachytherapy for all applicable disease sites
• Breast
• Sarcoma
• Skin
• Pediatrics

Insurance Affiliations:

• Aetna US HealthCare
• AmeriHealth HMO, Inc.
• Horizon Blue Cross Blue Shields
• Beech Street Corp.
• CIGNA HealthCare/CoMed HMO
• Family Choice Health Alliance, Inc.
• Horizon HMO
• Medicaid
• Medicare
• MediChoice
• Horizon NJ Health
• AmeriChoice of New Jersey Inc.
• Mutual Preferred
• Oxford Health Plans
• Private Healthcare Systems
• Health Net ( formerly PHS Health Plans )
• QualCare Preferred Providers
• Railroad Medicare
• University Health Plans, Inc.
• USA Health Network
  

Selected Peer-Reviewed Publications for the Recent 5 Years:

1. Khan AJ , Mehta PS, Zusag TW, Bonomi PD , Faber LP, Abrams RA, Is aggressive local-regional management warranted with oligometastatic non-small cell lung? . Radiother Oncol. 2006; 81(2):163-7.
2. Khan AJ, Kirk MC, Mehta PS, Seif NS, Griem KL, Bernard DA, Chu JCH and Dickler A., A dosimetric comparison of 3D conformal, IMRT, and Mammosite partial breast irradiation. Brachytherapy . 2006; 5: 183-188.
3. Hassaballa HA, Cohen ES, Khan AJ , Ali A, Bonomi P, Rubin DB , Positron-emission tomography demonstrates radiation induced changes to non-irradiated lungs in lung cancer patients treated with radiation and chemotherapy. Chest. 2005; 128:1448-1452.
4. Kim S, Rimm D, Carter D, Khan A , Parisot N, Franco MA, Bale A, Haffty BG, BRCA status, molecular markers, and clinical variables in early, conservatively managed breast cancer. Breast J. 2003 May-Jun;9(3):167-74.
5. Haffty BG, Harrold E, Khan A , Pathare P, Ward BA, Matloff E, Alvarez-Franco M, Bale AE, Conservatively Managed Breast Cancer in Young Women: Outcome as a Function of BRCA 1/2 Status. Lancet. 2002 27;359(9316):1471-7.
6. Khan AJ , King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG, Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2002 Feb;8(2):540-8.
7. Khan AJ , Haffty BG, The Location of Contralateral Breast Cancers After Radiation Therapy. Breast J 2001. Sept-Oct; 7(5): 331-6.
8. Khan AJ , DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG, Adenoid Cystic Carcinoma: A Retrospective Clinical Review. Int J Cancer 2001. Jun 20; 96(3):149-58.